Key facts
- It has raised $4.0M; the latest was Seed Round ($4.0M) in Dec 2025.
- Notable investors include Digital Health Venture Partners, Santé Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for beHuman
- ·The full record, as it builds
Funding rounds
No funding rounds for beHuman are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About beHuman
Developer of a tele-health platform intended for early cancer detection and preventive health screening services. The company offers a comprehensive suite of advanced cancer screenings, including genetic testing, blood-based biomarkers, in-home kits, and imaging, all delivered via a telehealth model, enabling clients to proactively manage their health and to detect potential cancer symptoms.
- Sector
- Healthcare
- HQ
- Miami Beach, FL, United States
- Founded
- 2024
- Employees
- 8
- Website
- behuman.health/
- Ownership
- Privately Held (backing)
beHuman doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in beHuman shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on beHuman in its N-PORT filings yet. We sweep new filings monthly.